116th SFO Congress

Article

The Congress of the French Ophthalmology Society, SFO, will take place at the Palais des Congres, 2 place de la Porte Maillot, Paris, France, 8-11 May 2010.

The Congress of the French Ophthalmology Society, SFO, will take place at the Palais des Congres, 2 place de la Porte Maillot, Paris, France, 8-11 May 2010.

The topic of the European Symposium is Progresses in research and care for lifelong good vision. It will be an opportunity for European associations to address the administrative supervision and reiterate that lifelong good vision is a medical fight. Invited delegates from foreign societies are coming this year from Chile, Syria and for the first time, from a US town, Chicago in 2010, other cities in the future.

Invited lectures are Enzymatic Vitreolysis by Marc de Smet (Lausanne, Switzerland), Femtoseconds and new corneal grafts by Rudy Nuijts (Maastricht, the Nederlands) and Adult strabismus: the Importance of surgical correction by Nathalie Azar (Chicago, USA).

French, European and US CME Credits are given for Teaching and News sessions and Round Tables in free access. Surgical skills transfer labs, operating throughout the congress, and interactive workshops in a large number, also give credits.

Visit www.sfo.asso.fr for more information.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.